Association of Parkinson's disease with infections and occupational exposure to possible vectors

Movement Disorders

Volumn 27, Issue 9, 2012, Pages 1111-1117

  Harris, M Anne ^a,b   Tsui, Joseph K ^a,c   Marion, Stephen A ^a   Shen, Hui ^a   Teschke, Kay ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal; Infection; Occupational; Parkinson's disease; Virus

Indexed keywords

ANTIPARKINSON AGENT; INFLUENZA VACCINE;

AGED; ANURA; ARTICLE; BIRD; CANADA; CASE CONTROL STUDY; CAT; CATTLE; CHICKEN; CHICKENPOX; CHILDHOOD DISEASE; CONTROLLED STUDY; CROUP; DISEASE ASSOCIATION; DUCK; FEMALE; FISH; GERBIL; GOAT; GOOSE; HAMSTER; HEALTH INSURANCE; HERPES ZOSTER; HORSE; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEASLES; MOUSE; MUMPS; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PARASITE VECTOR; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RUBELLA; SHEEP; SWINE; TURTLE; VIRUS INFECTION; VIRUS TRANSMISSION;

AGED; ANIMALS; BRITISH COLUMBIA; CASE-CONTROL STUDIES; CATS; CATTLE; DATABASES, FACTUAL; DISEASE VECTORS; FEMALE; HUMANS; INFECTION; INFLUENZA VACCINES; LOGISTIC MODELS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; PARKINSON DISEASE; PETS; RISK FACTORS; SMOKING; VIRUS DISEASES; ZOONOSES;

EID: 84864772346     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25077     Document Type: Article

References (43)

1. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003; 18: 19-31.
2. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157: 1015-1022.
3. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384-386.
4. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003; 39: 889-909.
5. Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol 2009; 169: 919-926.
6. Rugbjerg K, Harris MA, Shen H, Marion SA, Tsui JK, Teschke K. Pesticide exposure and risk of Parkinson's disease-a population-based case-control study evaluating the potential for recall bias. Scand J Work Environ Health 2011; 37: 10.
7. Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H. The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med 1995; 181: 2161-2169.
8. Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta 2009; 1792: 714-721.
9. Maurizi CP.Influenza caused epidemic encephalitis (encephalitis lethargica):the circumstantial evidence and a challenge to the nonbelievers. Med Hypotheses 2010; 74: 798 801.
10. Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 2007; 150: 963-976.
11. Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 2006; 67: 494-496.
12. Tsui JKC, Calne DB, Wang Y, Schulzer M, Marion SA. Occupational risk factors in Parkinson's disease. Can J Public Health 1999; 90: 334-337.
13. Tanner CM, Chen B, Wang W, et al. Environmental factors and Parkinson's disease: a case-control study in China. Neurology 1989; 39: 660-664.
14. Kuopio AM, Marttila RJ, Helenius H, Rinne UK. Environmental risk factors in Parkinson's disease. Mov Disord 1999; 14: 928-939.
15. Thomas DR, Salmon RL, Kench SM, et al. Zoonotic illness-determining risks and measuring effects: association between current animal exposure and a history of illness in a well characterised rural population in the UK. J Epidemiol Commun H 1994; 48: 151-155.
16. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ 1990; 301: 1015-1017.
17. Harris MA, Marion S, Spinelli JJ, Tsui JKC, Teschke K. Occupational whole body vibration exposure and Parkinson's disease: results from a population-based case-control study. Am J Epidemiol 2012 (In Press).
18. Toovey S, Jick SS, Meier CR. Parkinson's disease or Parkinson symptoms following seasonal influenza. Influenza Other Respi Viruses 2011; 5: 328-333.
19. Marttila RJ, Halonen P, Rinne UK. Influenza virus antibodies in parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls. Arch Neurol 1977; 34: 99-100.
20. Sasco AJ, Paffenbarger RS, Jr. Measles infection and Parkinson's disease. Am J Epidemiol 1985; 122: 1017-1031.
21. Marttila RJ, Rinne UK, Tiilikainen A. Virus antibodies in Parkinson's disease. Herpes simplex and measles virus antibodies in serum and CSF and their relation to HLA types. J Neurol Sci 1982; 54: 227-238.
22. Marttila RJ, Arstila P, Nikoskelainen J, Halonen PE, Rinne UK. Viral antibodies in the sera from patients with Parkinson disease. Eur Neurol 1977; 15: 25-33.
23. Elizan TS, Madden DL, Noble GR, et al. Viral antibodies in serum and CSF of parkinsonian patients and controls. Arch Neurol 1979; 36: 529-534.
24. Xu Q, Park Y, Huang X, et al. Physical activities and future risk of Parkinson disease. Neurology 2010; 75: 341-348.
25. Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology 2005; 64: 664-669.
26. Logroscino G, Sesso HD, Paffenbarger RS, Jr., Lee IM. Physical activity and risk of Parkinson's disease: a prospective cohort study. J Neurol Neurosurg Psychiatry 2006; 77: 1318-1322.
27. Busato A, Hofer D, Lentze T, Gaillard C, Burnens A. Prevalence and infection risks of zoonotic enteropathogenic bacteria in Swiss cow-calf farms. Vet Microbiol 1999; 69: 251-263.
28. de la Rua-Domenech R. Human Mycobacterium bovis infection in the United Kingdom: incidence, risks, control measures, and review of the zoonotic aspects of bovine tuberculosis. Tuberculosis (Edinb) 2006; 86: 77-109.
29. Grange JM, Yates MD. Zoonotic aspects of Mycobacterium bovis infection. Vet Microbiol 1994; 40: 137-151.
30. Hill SL, Cheney JM, Taton-Allen GF, Reif JS, Bruns C, Lappin MR. Prevalence of enteric zoonotic organisms in cats. J Am Vet Med Assoc 2000; 216: 687-692.
31. Tan JS. Human zoonotic infections transmitted by dogs and cats. Arch Intern Med 1997; 157: 1933-1943.
32. Cleaveland S, Laurenson MK, Taylor LH. Diseases of humans and their domestic mammals: pathogen characteristics, host range, and the risk of emergence. Philos Trans R Soc Lond B Biol Sci 2001; 356: 991-999.
33. Forrest HL, Webster RG. Perspectives on influenza evolution and the role of research. Anim Health Res Rev 2010; 11: 3-18.
34. Hertzman C, Wiens M, Snow B, Kelly S, Calne D. A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov Disord 1994; 9: 69-75.
35. Lange JH, Buja A, Mastrangelo G. Endotoxin, a possible agent in the causation of Parkinson's disease. J Occup Environ Med 2006; 48: 655; author reply, 655:656.
36. Lange JH, Niehaus I, Thomulka KW. Is endotoxin an environmental cause of Parkinson's disease? Neuroepidemiology 2003; 22: 313; author reply, 314.
37. Niehaus I, Lange JH. Endotoxin: is it an environmental factor in the cause of Parkinson's disease? Occup Environ Med 2003; 60: 378.
38. Fayerman P. Privacy law freezes health research. Vancouver Sun, January 9, 2008. Page A1. Available at: http://www.canada.com/vancouversun/news/story.html?id=a51318d3-777d-44f8-a403-20e 5fe9f891e. Accessed on March 20, 2012.
39. Teschke K, Marino S, Chu R, Tsui JKC, Harris MA, Marion SA. Public opinions about participating in health research. Can J Public Health 2010; 101: 159-164.
40. Harris MA, Levy AR, Teschke KE. Personal privacy and public health: potential impacts of privacy legislation on health research in Canada. Can J Public Health 2008; 99: 293-296.
41. Teschke K, Olshan AF, Daniels JL, et al. Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med 2002; 59: 575-593.
42. Krall EA, Valadian I, Dwyer JT, Gardner J. Recall of childhood illnesses. J Clin Epidemiol 1988; 41: 1059-1064.
43. Nelson LM, Franklin GM, Hamman RF, Boteler DL, Baum HM, Burks JS. Referral bias in multiple sclerosis research. J Clin Epidemiol 1988; 41: 187-192.